ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
Cholestasis Pruritus - Commercial
တချုးတၢ်ဟ့ၣ်စိဟ့ၣ်ကမီၤ
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါအီးကထိဘၢၣ် 01, 2025
တၢ်ဃုသ့ၣ်ညါတၢ်အစၢ
တၢ်ပာ်ဖျါ 4221 - 4226 လၢ 4226 အစၢတဖၣ်အကျါ
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP26-26 Commercial Pharmacy Benefit Exclusion for Select Medications
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါအ့ဖြ့ၣ် 08, 2026
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP25-26 MHCP Pharmacy Benefit Exclusion for Loargys
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါအ့ဖြ့ၣ် 08, 2026
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP24-26 Commercial Pharmacy Benefit Exclusion for Loargys
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါအ့ဖြ့ၣ် 08, 2026
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP23-26 Commercial and MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective June 1, 2026
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါအ့ဖြ့ၣ် 08, 2026
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP22-26 Preferred Drug List Update for Minnesota Health Care Programs (MHCP), Effective May 1, 2026
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါအ့ဖြ့ၣ် 08, 2026